MI
Healthcare & Life Sciences

miRdetect

miRdetect is a Healthcare & Life Sciences startup based in Germany, most recent round Series A, 1 tracked investor.

Activeseries-a
series-a
Stage
1
Investors

About miRdetect

Based in Germany, miRdetect is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

miRdetect develops and provides the M371-Test, a high-sensitivity liquid biopsy test that detects the miR-371a-3p microRNA biomarker in blood for the diagnosis and monitoring of testicular cancer.

Explore miRdetect's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Germany